ARTICLE | Company News
Paladin sales and marketing update
December 19, 2011 8:00 AM UTC
Paladin launched DigiFab in Canada to treat digoxin toxicity or overdose. Health Canada approved the polyclonal antibody against digoxin (digitalis) glycosides for the indication in January. Details were not disclosed (see BioCentury, Feb. 7). ...